The extracellular matrix (ECM) is a dynamic bioactive acellular environment, but its critical role in driving solid tumor development, immune-cell exclusion and therapy resistance is typically ...

"We developed a cell-free—or acellular—material that dynamically mimics the behavior of ECMs, which are key building blocks of mammalian tissues that are crucial for tissue structure and cell ...

These include approaches based on the use of collagen gel technology, cell-seeded scaffolds, acellular approaches, and the work in the laboratory of Francois Auger in Quebec, Canada, which he ...

DURHAM, N.C., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable ...

Symvess, or the ATEV™ (acellular tissue engineered vessel), is a first-in-class bioengineered human tissue that is designed to be a universally implantable vascular conduit for use in arterial ...

The vessels, called acellular tissue-engineered vessels (ATEVs), are grown in a lab from cultured human cells and then undergo treatment to prevent immune rejection. When implanted, the patient's ...

Humacyte (HUMA) announced the publication of the Budget Impact Model for Symvess in the Journal of Medical Economics. The publication, titled ...

One hypothesis is that the switch from a vaccine containing whole Bordetella pertussis cells to an acellular version with pertussis antigens—a change that happened in the US around the year 2000—might ...